NCT02750202 2026-01-23
TheraVACCS
University of Pretoria
Phase 3 Completed
Clinical Trials
9 trialsNCT06866574 2025-07-31
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
Xiamen University
Phase 3 Active not recruiting
NCT05056402 2025-07-22
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Xiamen University
Phase 3 Active not recruiting
NCT04782895 2023-06-15
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Xiamen University
Phase 3 Completed
NCT03289260 2020-09-23
AdAM
Medical University Innsbruck
Phase 3 Unknown
NCT03853785 2019-03-12
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts
Assiut University
Phase 3 Unknown
NCT03296397 2018-02-27
CONDYVAC
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT00501137 2015-04-10
BCGov-01
University of British Columbia
Phase 3 Completed
NCT00999986 2009-11-25
Low Dose Cyclophosphamide Treats Genital Warts
Huazhong University of Science and Technology
Phase 3 Completed